Request Trial
designer491
designer491 / iStockphoto.com
15 November 2017Americas

Excision Bio licenses CRISPR technology from UC Berkeley

Excision BioTherapeutics has become the first company to secure exclusive licences from the University of California (UC), Berkeley for “newly discovered” CRISPR gene editors.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
US judge allows rare patent defence in ‘world’s smallest heart pump’ suit
5 May 2026   J&J’s Abiomed can proceed with its non-infringement defence despite potential future appellate reversal, in a week when both parties in the case were dealt wins and losses in their clash over Impella devices.
Americas
WATCH: Interview with Ben Doranz, president and CEO, Integral Molecular
4 May 2026   LSIPR's senior reporter Marisa Woutersen speaks with Ben Doranz of Integral Molecular, fresh from the stage at LSPN Boston after speaking at a panel session on challenges in antibody patent protection.
Americas
Brussels under scrutiny for IP policy as US flags risks to innovation
1 May 2026   The Office of the US Trade Representative has placed the EU on its Watch List, outlining concerns about pharma legislation, GIs and digital copyright.


Editor's picks

From the courtroom: Hikma v Amarin SCOTUS oral arguments
Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026

Editor's picks

Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026

More features

US judge allows rare patent defence in ‘world’s smallest heart pump’ suit
WATCH: John Ward, trademarks VP and associate GC of Moderna, at INTA
WATCH: Interview with Ben Doranz, president and CEO, Integral Molecular
Brussels under scrutiny for IP policy as US flags risks to innovation
Squire Patton Boggs promotes partner to head Europe IP&T practice
From the courtroom: Hikma v Amarin SCOTUS oral arguments
Report: 85% of in-house counsel want IP service providers to embrace AI
Moderna loses key mRNA patent in European vaccine fight